1. Home
  2. BHVN vs PJT Comparison

BHVN vs PJT Comparison

Compare BHVN & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • PJT
  • Stock Information
  • Founded
  • BHVN 2013
  • PJT 2014
  • Country
  • BHVN United States
  • PJT United States
  • Employees
  • BHVN N/A
  • PJT N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • PJT Investment Managers
  • Sector
  • BHVN Health Care
  • PJT Finance
  • Exchange
  • BHVN Nasdaq
  • PJT Nasdaq
  • Market Cap
  • BHVN 3.6B
  • PJT 3.8B
  • IPO Year
  • BHVN 2017
  • PJT N/A
  • Fundamental
  • Price
  • BHVN $39.17
  • PJT $163.65
  • Analyst Decision
  • BHVN Strong Buy
  • PJT Hold
  • Analyst Count
  • BHVN 13
  • PJT 5
  • Target Price
  • BHVN $63.00
  • PJT $141.75
  • AVG Volume (30 Days)
  • BHVN 1.2M
  • PJT 246.8K
  • Earning Date
  • BHVN 02-27-2025
  • PJT 02-04-2025
  • Dividend Yield
  • BHVN N/A
  • PJT 0.61%
  • EPS Growth
  • BHVN N/A
  • PJT 20.14
  • EPS
  • BHVN N/A
  • PJT 3.78
  • Revenue
  • BHVN N/A
  • PJT $1,345,850,000.00
  • Revenue This Year
  • BHVN N/A
  • PJT $21.99
  • Revenue Next Year
  • BHVN $197.13
  • PJT $13.68
  • P/E Ratio
  • BHVN N/A
  • PJT $43.75
  • Revenue Growth
  • BHVN N/A
  • PJT 21.75
  • 52 Week Low
  • BHVN $26.80
  • PJT $88.51
  • 52 Week High
  • BHVN $62.21
  • PJT $168.92
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 51.03
  • PJT 59.98
  • Support Level
  • BHVN $35.01
  • PJT $158.23
  • Resistance Level
  • BHVN $39.36
  • PJT $166.00
  • Average True Range (ATR)
  • BHVN 2.07
  • PJT 3.70
  • MACD
  • BHVN 0.50
  • PJT 0.94
  • Stochastic Oscillator
  • BHVN 77.83
  • PJT 96.99

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement fees, and others. Geographically, It generates a majority of its revenue from the United States.

Share on Social Networks: